AROA BIOSURGERY LIMITED — Director's Dealing 2020

Dec 9, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	John Diddams
Date of last notice	27 July 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

be disclosed in this part.
Direct or indirect interest		Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.		Whitfield Investments Pty Ltd <John FDiddams Family Trust> (Beneficiary)Galdarn Pty Ltd (Beneficiary)
Date of change		9 December 2020
No. of securities held prior to change		IndirectWhitfield Investments Pty Ltd<John FDiddams Family Trust>633,675 Fully Paid Ordinary Share495,000 Options exercisable at $0.1075expiring 30 November 2029.Galdarn Pty Ltd213,875 Fully Paid Ordinary Shares
Class		(a) Ordinary Fully Paid Shares(b) Options exercisable at $0.30 (30 cents)per Option, on or before 30 November2020
Number acquired		(a) 165,000
Number disposed		(b) 165,000

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration	$17,737.50	$17,737.50
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	Indirect
	Whitfield	Investments Pty Ltd<John F
	Diddams Family Trust>
	798,675	Fully Paid Ordinary Share
	330,000	Options exercisable at $0.1075
		expiring 30 November 2029.
	Galdarn Pty Ltd
	213,875	Fully Paid Ordinary Shares
Nature of change	Exercise	of Options
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation
in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder	-
(if issued securities)
Date of change	-
No. and class of securities to	-
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	-
Interest disposed	-
Value/Consideration	-
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change	-

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date N/A was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011